Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Innovative and Linguistically-Tailored Mobile Intervention to Improve Follow-Up for Abnormal Pap Test Results: CervixChat

NCT04821297 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT04821297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04821297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Innovative and Linguistically-Tailored Mobile Intervention to Improve Follow-Up for Abnormal Pap Test Results: CervixChat
Lead sponsor
Thomas Jefferson University
Phase
Not applicable
Overall status
Completed
Start date
February 18, 2021
Completion date
September 10, 2021
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical carcinoma